Dexrazoxane
Dexrazoxane for Injection
- Strength
- 250 mg/25mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Class
- Cytoprotective Agent
Fosun Pharma USA Inc.
Not stocked by us — reference only
Listed by Novadoz Pharmaceuticals LLC
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Drug class | Cytoprotective Agent |
| Approval route | ANDA — approved generic |
| NDC code | 72205-248 |
| FDA application | ANDA216748 |
| RxNorm concept | 1736585 |
| Package sizes listed | 1 |
| Marketed since | March 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Dexrazoxane for Injection
Fosun Pharma USA Inc.
Not stocked by us — reference only
Dexrazoxane for Injection
Fosun Pharma USA Inc.
Not stocked by us — reference only
Dexrazoxane for Injection
Almaject, Inc.
Not stocked by us — reference only
Dexrazoxane for Injection
Gland Pharma Limited
Not stocked by us — reference only
Dexrazoxane for Injection
Gland Pharma Limited
Not stocked by us — reference only
Novadoz Pharmaceuticals LLC
Not stocked by us — reference only
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Hikma Pharmaceuticals USA Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.